Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:44 PM
Ignite Modification Date:
2025-12-24 @ 4:44 PM
NCT ID:
NCT00614666
Eligibility Criteria:
Inclusion Criteria:
* Age \>= 18 years and \<= 50 years
* Male or Female (if female, must have a negative pregnancy test and agree to use an acceptable contraception method)
* Able to understand study and give written informed consent
* Have a respiratory illness with at least one of the following: Cough, chest pain dyspnea or tachypnea, sputum production, or fever/chills/night sweats
* Have a new or suspected new pulmonary infiltrate on Chest X-ray
* Have a positive coccidioidal serology by EIA or immunodiffusion
Exclusion Criteria:
* Patients under the age of 18 years or over 50 years
* Patients with a prior history of confirmed coccidioidal infection
* Laboratory diagnosis of another etiology for the inclusion-defining illness
* Inability to comprehend study and provide informed consent
* History of or current evidence of major organ disease
* Concomitant use of prednisone and other corticosteroids not permitted
* Concomitant immunosuppressive therapy is not permitted
* Concomitant antibacterial therapy is not permitted
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT00614666
Study Brief:
Protocol Section:
NCT00614666